Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

China flag China · Delayed Price · Currency is CNY
127.61
+1.48 (1.17%)
May 20, 2026, 11:54 AM CST
Market Cap20.09B +314.9%
Revenue (ttm)417.21M -0.4%
Net Income-215.28M
EPS-1.35
Shares Out159.27M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,549,845
Average Volume8,694,455
Open122.01
Previous Close126.13
Day's Range122.01 - 130.98
52-Week Range28.03 - 188.93
Beta1.23
RSI61.25
Earnings DateApr 29, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China. [Read more]

Sector Healthcare
Founded 2001
Employees 760
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300436
Full Company Profile

Financial Performance

In 2025, SHE:300436's revenue was 416.37 million, a decrease of -5.68% compared to the previous year's 441.46 million. Losses were -217.85 million, 39.4% more than in 2024.

Financial Statements